Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H G M Leufkens

Showing results (1-10 of 109) with videos related to

Pageof 11
Sort By:
The Netherlands Journal of Medicine|November 15, 2002
Pharmacoepidemiological modelling: Markov models of antibiotic use in patients with diabetesH G M Leufkens
European Journal of Clinical Pharmacology|May 3, 2005
Changes in the defined daily dose; CYP2D6/CYP3A metabolism as an indicator for dose-setting problemsP Stolk, E R Heerdink, H G M Leufkens
European Journal of Cancer (Oxford, England : 1990)|July 22, 2018
The use of real-world data in cancer drug developmentE Skovlund, H G M Leufkens, J F Smyth
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|August 16, 2002
Does a fracture at one site predict later fractures at other sites? A British cohort studyT P van Staa, H G M Leufkens, C Cooper
Bone|October 26, 2002
Utility of medical and drug history in fracture risk prediction among men and womenT P van Staa, H G M Leufkens, C Cooper
Pharmacoepidemiology and Drug Safety|May 10, 2002
Fate of abstracts presented at five International Conferences on Pharmacoepidemiology (ICPE): 1995-1999P Stolk, A C G Egberts, H G M Leufkens
Arthritis and Rheumatism|August 1, 2008
Changes in the characteristics of patients prescribed selective cyclooxygenase 2 inhibitors after the 2004 withdrawal of rofecoxibE Setakis, H G M Leufkens, T P van Staa
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|October 16, 2002
The epidemiology of corticosteroid-induced osteoporosis: a meta-analysisT P van Staa, H G M Leufkens, C Cooper
Journal of Pharmaceutical Policy and Practice|April 2, 2021
Linking market authorizations of medicines with disease burden in South AfricaK Narsai, H G M Leufkens, A K Mantel-Teeuwisse
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 22, 2010
Proton pump inhibitors, fracture risk and selection bias: three studies, same database, two answersF de Vries, T-P van Staa, H G M Leufkens
Pageof 11

Showing results (1-10 of 109) with videos related to

Sort By:
Pageof 11
The Netherlands Journal of Medicine|November 15, 2002
Pharmacoepidemiological modelling: Markov models of antibiotic use in patients with diabetesH G M Leufkens
European Journal of Clinical Pharmacology|May 3, 2005
Changes in the defined daily dose; CYP2D6/CYP3A metabolism as an indicator for dose-setting problemsP Stolk, E R Heerdink, H G M Leufkens
European Journal of Cancer (Oxford, England : 1990)|July 22, 2018
The use of real-world data in cancer drug developmentE Skovlund, H G M Leufkens, J F Smyth
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|August 16, 2002
Does a fracture at one site predict later fractures at other sites? A British cohort studyT P van Staa, H G M Leufkens, C Cooper
Bone|October 26, 2002
Utility of medical and drug history in fracture risk prediction among men and womenT P van Staa, H G M Leufkens, C Cooper
Pharmacoepidemiology and Drug Safety|May 10, 2002
Fate of abstracts presented at five International Conferences on Pharmacoepidemiology (ICPE): 1995-1999P Stolk, A C G Egberts, H G M Leufkens
Arthritis and Rheumatism|August 1, 2008
Changes in the characteristics of patients prescribed selective cyclooxygenase 2 inhibitors after the 2004 withdrawal of rofecoxibE Setakis, H G M Leufkens, T P van Staa
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|October 16, 2002
The epidemiology of corticosteroid-induced osteoporosis: a meta-analysisT P van Staa, H G M Leufkens, C Cooper
Journal of Pharmaceutical Policy and Practice|April 2, 2021
Linking market authorizations of medicines with disease burden in South AfricaK Narsai, H G M Leufkens, A K Mantel-Teeuwisse
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 22, 2010
Proton pump inhibitors, fracture risk and selection bias: three studies, same database, two answersF de Vries, T-P van Staa, H G M Leufkens
Pageof 11